3 Growth Companies With Insider Ownership Up To 25%

As the U.S. stock market experiences fluctuations with indices like the S&P 500 retreating from record highs, investor optimism remains buoyed by strong corporate earnings and resilient economic data. In such a climate, growth companies with substantial insider ownership can be appealing due to their potential alignment of interests between company insiders and shareholders, offering a measure of confidence in navigating market uncertainties.

Top 10 Growth Companies With High Insider Ownership In The United States

Click here to see the full list of 191 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Liquidia (LQDA)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Liquidia Corporation is a biopharmaceutical company focused on developing, manufacturing, and commercializing products for unmet patient needs in the United States, with a market cap of approximately $1.21 billion.

Operations: The company generates revenue primarily from its pharmaceuticals segment, which amounted to $14.14 million.

Insider Ownership: 11.2%

Liquidia's growth prospects are bolstered by the recent FDA approval of YUTREPIA, a treatment for pulmonary arterial hypertension and interstitial lung disease, utilizing their proprietary PRINT technology. The company's revenue is projected to grow significantly faster than the US market average. Despite legal challenges from United Therapeutics over patent issues, Liquidia remains poised for profitability within three years. However, its share price has been highly volatile recently and trades well below estimated fair value.

• Delve into the full analysis future growth report here for a deeper understanding of Liquidia.
• Our comprehensive valuation report raises the possibility that Liquidia is priced higher than what may be justified by its financials.

Elastic (ESTC)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Elastic N.V. is a search artificial intelligence company that offers software platforms for hybrid, public or private clouds, and multi-cloud environments globally, with a market cap of $8.98 billion.

Operations: The company's revenue is primarily generated from its Software & Programming segment, which amounts to $1.48 billion.

Insider Ownership: 12.5%

Elastic's growth trajectory is supported by a strategic collaboration with AWS, enhancing AI capabilities and expanding market reach. Despite recent insider selling and no substantial insider buying, the company trades below its estimated fair value. Revenue is projected to grow faster than the US market average but slower than 20% annually. Elastic's forecasted profitability within three years aligns with above-average market growth expectations, while recent earnings showed reduced net losses amid increased revenues.

• Click here and access our complete growth analysis report to understand the dynamics of Elastic.
• In light of our recent valuation report, it seems possible that Elastic is trading behind its estimated value.

Hinge Health (HNGE)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Hinge Health, Inc. develops healthcare software focused on joint and muscle health, with a market cap of $3.66 billion.

Operations: The company generates revenue from its healthcare software segment, amounting to $431.52 million.

Insider Ownership: 25.8%

Hinge Health's recent IPO raised US$437.31 million, supporting its growth in the digital musculoskeletal care space. The company's earnings are forecast to grow significantly at 21.3% per year, outpacing the US market average. With no substantial insider trading activity reported recently, Hinge Health remains a key player in MSK care through partnerships like Cigna Healthcare and innovative offerings such as HingeSelect, which integrates digital and in-person care for cost-effective treatment solutions.

• Click to explore a detailed breakdown of our findings in Hinge Health's earnings growth report.
• The analysis detailed in our Hinge Health valuation report hints at an deflated share price compared to its estimated value.

Taking Advantage

• Investigate our full lineup of 191 Fast Growing US Companies With High Insider Ownership right here.
• Ready To Venture Into Other Investment Styles? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 20 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com